Search

Your search keyword '"Claes, K"' showing total 752 results

Search Constraints

Start Over You searched for: Author "Claes, K" Remove constraint Author: "Claes, K"
752 results on '"Claes, K"'

Search Results

3. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

4. Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq

5. OP0306-HPR POINTS TO CONSIDER FOR PATIENT EDUCATION PROVIDED BY NURSES ON METHOTREXATE USE. A EUROPEAN CONSENSUS INITIATIVE

6. OP0274-HPR PATIENTS’ AND CLINICIANS’ PERSPECTIVES AND EXPERIENCES ON EDUCATION AND SUPPORT ABOUT METHOTREXATE: FINDINGS FROM A SURVEY TO 24 EUROPEAN COUNTRIES

11. PRECISION : the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

16. Do Realistic Contexts and Graphical Representations Always Have a Beneficial Impact on Students' Performance? Negative Evidence from a Study on Modeling Non-Linear Geometry Problems.

17. PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.

23. Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing

30. Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq

32. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort

33. Questioning the Pathogenic Role of the GLA p.Ala143Thr “Mutation” in Fabry Disease: Implications for Screening Studies and ERT

37. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

38. Erratum: Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome (J. Exp. Med. (2020) 217:6 Doi:10.1084/jem.20191804)

40. Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

43. Real-Life Gait Performance as a Digital Biomarker for Motor Fluctuations: The Parkinson@Home Validation Study

44. Reply to Kratz et al.

45. Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes

46. Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome

47. Effect of an intervention on the congruence of nurses' and patients' perceptions of patient‐centred care: A pre‐test post‐test study

Catalog

Books, media, physical & digital resources